Department of Cardiac Surgery, Dr Antoni Jurasz Memorial University Hospital in Bydgoszcz, Bydgoszcz, Poland; Department of Hygiene, Epidemiology and Ergonomics, Division of Ergonomics and Physical Effort, Collegium Medicum UMK in Bydgoszcz, Bydgoszcz, Poland.
Department of Cardiac Surgery, Dr Antoni Jurasz Memorial University Hospital in Bydgoszcz, Bydgoszcz, Poland.
J Thorac Cardiovasc Surg. 2017 Apr;153(4):865-875.e12. doi: 10.1016/j.jtcvs.2016.11.057. Epub 2016 Dec 19.
To investigate the potential beneficial effects of posterior pericardial drainage in patients undergoing heart surgery.
Multiple online databases and relevant congress proceedings were screened for randomized controlled trials assessing the efficacy and safety of posterior pericardial drainage, defined as posterior pericardiotomy incision, chest tube to posterior pericardium, or both. Primary endpoint was in-hospital/30 days' cardiac tamponade. Secondary endpoints comprised death or cardiac arrest, early and late pericardial effusion, postoperative atrial fibrillation (POAF), acute kidney injury, pulmonary complications, and length of hospital stay.
Nineteen randomized controlled trials that enrolled 3425 patients were included. Posterior pericardial drainage was associated with a significant 90% reduction of the odds of cardiac tamponade compared with the control group: odds ratio (95% confidence interval) 0.13 (0.07-0.25); P < .001. The corresponding event rates were 0.42% versus 4.95%. The odds of early and late pericardial effusion were reduced significantly in the intervention arm: 0.20 (0.11-0.36); P < .001 and 0.05 (0.02-0.10); P < .001, respectively. Posterior pericardial drainage significantly reduced the odds of POAF by 58% (P < .001) and was associated with significantly shortened (by nearly 1 day) overall length of hospital stay (P < .001). Reductions in postoperative complications translated into significantly reduced odds of death or cardiac arrest (P = .03) and numerically lower odds of acute kidney injury (P = .08).
Posterior pericardial drainage is safe and simple technique that significantly reduces not only the prevalence of early pericardial effusion and POAF but also late pericardial effusion and cardiac tamponade. These benefits, in turn, translate into improved survival after heart surgery.
研究心脏手术后经心后心包引流的潜在有益效果。
通过筛选多个在线数据库和相关会议记录,评估了经心后心包切开术、心包引流管置于心后心包、或两者联合应用的疗效和安全性的随机对照试验。主要终点是院内/30 天心脏压塞。次要终点包括死亡或心脏骤停、早期和晚期心包积液、术后心房颤动(POAF)、急性肾损伤、肺部并发症和住院时间。
纳入了 19 项随机对照试验,共纳入 3425 例患者。与对照组相比,心后心包引流显著降低了心脏压塞的几率:比值比(95%置信区间)为 0.13(0.07-0.25);P < 0.001。相应的发生率分别为 0.42%和 4.95%。干预组早期和晚期心包积液的发生几率显著降低:0.20(0.11-0.36);P < 0.001和 0.05(0.02-0.10);P < 0.001。心后心包引流显著降低了 POAF 的发生几率 58%(P < 0.001),并显著缩短了总住院时间(近 1 天)(P < 0.001)。术后并发症的减少转化为死亡或心脏骤停几率的显著降低(P = 0.03),以及急性肾损伤几率的降低(P = 0.08)。
心后心包引流是一种安全且简单的技术,不仅显著降低了早期心包积液和 POAF 的发生率,还降低了晚期心包积液和心脏压塞的发生率。这些益处反过来又提高了心脏手术后的生存率。